Ryzumvi (phentolamine mesylate)

**Product type:** Human Prescription Drug

**Active ingredient:** PHENTOLAMINE MESYLATE

**Strength:** 10 mg/mL

**Dosage form:** Solution/ Drops

**Route:** Ophthalmic

**Labeler:** Oyster Point Pharma, Inc.

**Marketing category:** NDA (NDA217064)

**Pharmacologic class:** Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]